Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immune modulatory effects of radiotherapy as basis for well-reasoned radioimmunotherapies
Michael Rückert, Lisa Deloch, Rainer Fietkau, et al.
Strahlentherapie und Onkologie (2018) Vol. 194, Iss. 6, pp. 509-519
Closed Access | Times Cited: 100

Showing 1-25 of 100 citing articles:

Tumor Microenvironment as A “Game Changer” in Cancer Radiotherapy
Magdalena Jarosz‐Biej, Ryszard Smolarczyk, Tomasz Cichoń, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 13, pp. 3212-3212
Open Access | Times Cited: 420
HSP70 Multi-Functionality in Cancer
Zarema Albakova, Grigoriy A. Armeev, Leonid M. Kanevskiy, et al.
Cells (2020) Vol. 9, Iss. 3, pp. 587-587
Open Access | Times Cited: 207
Trial watch: Peptide-based vaccines in anticancer therapy
Lucillia Bezu, Oliver Kepp, Giulia Cerrato, et al.
OncoImmunology (2018) Vol. 7, Iss. 12, pp. e1511506-e1511506
Open Access | Times Cited: 144
Abscopal effect in radioimmunotherapy
Milad Ashrafizadeh, Bagher Farhood, Ahmed Eleojo Musa, et al.
International Immunopharmacology (2020) Vol. 85, pp. 106663-106663
Closed Access | Times Cited: 112
Clinically Relevant Radiation Exposure Differentially Impacts Forms of Cell Death in Human Cells of the Innate and Adaptive Immune System
Sylvia E. Falcke, Paul F. Rühle, Lisa Deloch, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 11, pp. 3574-3574
Open Access | Times Cited: 84
Tumor hypoxia and radiotherapy: A major driver of resistance even for novel radiotherapy modalities
Claire Beckers, Martin Pruschy, Irene Vetrugno
Seminars in Cancer Biology (2023) Vol. 98, pp. 19-30
Open Access | Times Cited: 36
Nanoparticle-based drug delivery systems to enhance cancer immunotherapy in solid tumors
Jiaxin Zhang, Siyuan Wang, D D Zhang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 23
Combining PARP Inhibition, Radiation, and Immunotherapy: A Possible Strategy to Improve the Treatment of Cancer?
Mathieu Césaire, Juliette Thariat, Serge M. Candéias, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 12, pp. 3793-3793
Open Access | Times Cited: 71
Safety and efficacy of single cycle induction treatment with cisplatin/docetaxel/ durvalumab/tremelimumab in locally advanced HNSCC: first results of CheckRad-CD8
Markus Hecht, Antoniu‐Oreste Gostian, Markus Eckstein, et al.
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 2, pp. e001378-e001378
Open Access | Times Cited: 67
Radiomics to predict outcomes and abscopal response of patients with cancer treated with immunotherapy combined with radiotherapy using a validated signature of CD8 cells
Roger Sun, Nora Sundahl, Markus Hecht, et al.
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 2, pp. e001429-e001429
Open Access | Times Cited: 65
Radiotherapy Both Promotes and Inhibits Myeloid-Derived Suppressor Cell Function: Novel Strategies for Preventing the Tumor-Protective Effects of Radiotherapy
Suzanne Ostrand‐Rosenberg, Lucas A. Horn, Nicholas G. Ciavattone
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 63
Integrating Loco-Regional Hyperthermia Into the Current Oncology Practice: SWOT and TOWS Analyses
Niloy R. Datta, H. Petra Kok, Johannes Crezee, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 63
Increased heat shock protein 70 (Hsp70) serum levels and low NK cell counts after radiotherapy – potential markers for predicting breast cancer recurrence?
Anna Rothammer, Eva K. Sage, Caroline Werner, et al.
Radiation Oncology (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 57
The Influence of Radiation on Bone and Bone Cells—Differential Effects on Osteoclasts and Osteoblasts
Anna-Jasmina Donaubauer, Lisa Deloch, Ina Becker, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 17, pp. 6377-6377
Open Access | Times Cited: 57
Induction chemoimmunotherapy followed by CD8+ immune cell-based patient selection for chemotherapy-free radioimmunotherapy in locally advanced head and neck cancer
Markus Hecht, Markus Eckstein, Sandra Rutzner, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 1, pp. e003747-e003747
Open Access | Times Cited: 33
Immune Escape Strategies in Head and Neck Cancer: Evade, Resist, Inhibit, Recruit
Kourtney L. Kostecki, Mari Iida, Bridget E. Crossman, et al.
Cancers (2024) Vol. 16, Iss. 2, pp. 312-312
Open Access | Times Cited: 6
Radiotherapy is an independent prognostic marker of favorable prognosis in non‐small cell lung cancer patients after treatment with the immune checkpoint inhibitor, nivolumab
Ou Yamaguchi, Kyoichi Kaira, Kosuke Hashimoto, et al.
Thoracic Cancer (2019) Vol. 10, Iss. 4, pp. 992-1000
Open Access | Times Cited: 48
Gas plasma irradiation of breast cancers promotes immunogenicity, tumor reduction, and an abscopal effect in vivo
Hamed Mahdikia, Fariba Saadati, Eric Freund, et al.
OncoImmunology (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 48
Immune biological rationales for the design of combined radio- and immunotherapies
Michael Häder, Benjamin Frey, Rainer Fietkau, et al.
Cancer Immunology Immunotherapy (2020) Vol. 69, Iss. 2, pp. 293-306
Open Access | Times Cited: 45
Combinations of Radiotherapy with Vaccination and Immune Checkpoint Inhibition Differently Affect Primary and Abscopal Tumor Growth and the Tumor Microenvironment
Michael Rückert, Lisa Deloch, Benjamin Frey, et al.
Cancers (2021) Vol. 13, Iss. 4, pp. 714-714
Open Access | Times Cited: 37
Identification of 15 lncRNAs Signature for Predicting Survival Benefit of Advanced Melanoma Patients Treated with Anti-PD-1 Monotherapy
Jian‐Guo Zhou, Bo Liang, Jianguo Liu, et al.
Cells (2021) Vol. 10, Iss. 5, pp. 977-977
Open Access | Times Cited: 35
Imaging approaches and radiomics: toward a new era of ultraprecision radioimmunotherapy?
Roger Sun, Théophraste Henry, Adrien Laville, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 7, pp. e004848-e004848
Open Access | Times Cited: 25
The Effect of Hyperthermia and Radiotherapy Sequence on Cancer Cell Death and the Immune Phenotype of Breast Cancer Cells
Azzaya Sengedorj, Michael Häder, Lukas Heger, et al.
Cancers (2022) Vol. 14, Iss. 9, pp. 2050-2050
Open Access | Times Cited: 23
Metabolism and Gut Microbiota in Cancer Immunoediting, CD8/Treg Ratios, Immune Cell Homeostasis, and Cancer (Immuno)Therapy: Concise Review
Irina Kareva
Stem Cells (2019) Vol. 37, Iss. 10, pp. 1273-1280
Open Access | Times Cited: 42
Radiochemotherapy combined with NK cell transfer followed by second-line PD-1 inhibition in a patient with NSCLC stage IIIb inducing long-term tumor control: a case study
Konrad Kokowski, Stefan Stangl, Sophie Seier, et al.
Strahlentherapie und Onkologie (2019) Vol. 195, Iss. 4, pp. 352-361
Open Access | Times Cited: 41
Page 1 - Next Page

Scroll to top